Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caribou Biosciences Inc
(NQ:
CRBU
)
2.230
+0.100 (+4.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Caribou Biosciences Inc
< Previous
1
2
3
4
Next >
Caribou Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
August 14, 2024
Via
Benzinga
Evaluating Caribou Biosciences: Insights From 4 Financial Analysts
July 17, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 03, 2024
Via
Benzinga
Attention Biotech Investors - Stocks To Watch
May 16, 2024
RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences,...
Via
Benzinga
Expert Ratings For Caribou Biosciences
May 16, 2024
Via
Benzinga
3 Underappreciated Stocks That Could 10x in 10 Years
May 12, 2024
10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line.
Via
InvestorPlace
CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
CRBU stock results show that Caribou Biosciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
April 05, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points
March 13, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index remained in the "Greed" zone on Tuesday.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Gold Down Over 1%; ClearOne Shares Spike Higher
March 12, 2024
U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on Tuesday. The Dow traded up 0.74% to 39,057.10 while the NASDAQ rose 1.41% to 16,245.83. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 12, 2024
Via
Benzinga
Why Caribou Biosciences Stock Is Crashing Today
March 12, 2024
Investors didn't like the clinical-stage biotech's Q4 update for one key reason.
Via
The Motley Fool
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
February 26, 2024
Buy this stock if you're daring, but avoid it for now if you aren't.
Via
The Motley Fool
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
February 12, 2024
It's less scary to take on risky investments when the market is rising.
Via
The Motley Fool
3 Biotech Stocks You Can Buy and Hold for the Next Decade
January 15, 2024
These companies are still in the early innings of their growth potential.
Via
The Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
Gene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR.
Via
InvestorPlace
Exposures
Product Safety
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.
Via
InvestorPlace
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
Via
The Motley Fool
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
November 17, 2023
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
2 Top Growth Stocks to Buy Right Now Without Hesitation
October 20, 2023
These stocks are dirt cheap right now.
Via
The Motley Fool
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge...
Via
Benzinga
2 Exciting Biotech Stocks to Buy With Less Than $10
October 11, 2023
You can pick up these stocks for a song right now.
Via
The Motley Fool
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...
Via
Benzinga
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip
October 10, 2023
Wall Street price targets suggest this stock can rocket more than 400% higher.
Via
The Motley Fool
2 Magnificent Growth Stocks to Buy On the Dip
September 27, 2023
It might be time to catch these falling knives.
Via
The Motley Fool
1 Gene Editing Stock to Buy Now, and 1 to Sell
September 23, 2023
Target markets matter. So does having the cash to get to them.
Via
The Motley Fool
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
September 18, 2023
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.